Powered Research

Founded in 2017 and headquartered in Boston, Massachusetts, Powered Research is a private, revenue-generating CRO with a core operational facility in Durham, North Carolina. The company leverages a team of 70 domain experts to deliver tailored preclinical study services, primarily in ocular and oncology drug development, boasting a 97% client retention rate for repeat studies within six months. Its business model is purely service-based, providing critical non-GLP pharmacology, tolerability, and drug distribution studies to accelerate early-stage therapeutic innovation for its clients.

Integrated preclinical service platform specializing in non-GLP in vivo studies for ophthalmology and oncology. Capabilities include a 20K sq ft AAALAC-accredited vivarium, custom experimental design, validated tolerability/pharmacology models, drug distribution studies, and expert consulting from board-certified veterinary ophthalmologists/toxicologists.

Powered Research competes in the fragmented preclinical CRO market, facing large full-service players (e.g., Charles River, Labcorp) and other niche specialists. Its differentiation lies in its dual ophthalmology/oncology focus, rapid turnaround, and deep scientific expertise in non-GLP studies, appealing to clients needing specialized, fast-paced early development support.